Navigation Links
CorVel Announces Record Earnings Per Share
Date:2/5/2008

cial results, business expansion and benefits of acquisitions. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company's actual results to differ materially and adversely from those expressed in any forward-looking statement.

The risks and uncertainties referred to above include, but are not limited to, factors described in this press release and the Company's filings with the Securities and Exchange Commission, including "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended March 31, 2007. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason.

CorVel Corporation

Quarterly Results - Income Statement (unaudited)

Quarter ended December 31, 2006 and 2007

Quarter Ended Quarter Ended

December 31, December 31,

2006 2007

Revenues 66,580,000 76,678,000

Cost of revenues 51,048,000 56,279,000

Gross profit 15,532,000 20,399,000

General and administrative 9,263,000 10,584,000

Income from operations 6,269,000 9,815,000

Income tax expense 2,444,000 3,829,000

Net income 3,825,000 5,986,000

Earnings Per Share:

Basic $0.27 $0.43

Diluted $0.27 $0.43

Weighted Shares

Basic
'/>"/>

SOURCE CorVel Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. CorVel Corporation Announces Resumption of Stock Repurchases
2. Better Nutrition Announces Best Of Beauty Awards Winners Showcasing the Best Natural Beauty Products of 2008
3. Naviscan Announces a New Chairman and Board Member
4. Globus Medical Announces Record Revenue for 2007
5. HealthFitness Announces Executive Changes: Chief Operations Officer And New Medical Officer Appointed; Vice Chairman Retires
6. Sharps Compliance Corp. Announces 20% Growth in Customer Billings for Second Quarter of Fiscal Year 2008
7. Sergeants(R) Pet Care Products Announces Cause Marketing Partnership With the National Wildlife Federation
8. Poniard Pharmaceuticals Announces Upcoming Conference Participation
9. Mirixa Corporation Announces Leadership Change
10. Medco Announces Date for Fourth-Quarter and Full-Year 2007 Financial Results
11. Finola Hughes Announces Her Best Accessory at Fashion Week
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17 2009 6162 1Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17 2009 6162 2Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 1Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 2Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 3Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 4Shire Re Launches FOCUS an Online Personalized Patient Support Program for Adults with ADHD Taking Vyvanse 28R 29 28lisdexamfetamine dimesylate 29 6160 5Natural Alternatives International Inc Announces Filing of Patent Infringement Lawsuit 6158 1Natural Alternatives International Inc Announces Filing of Patent Infringement Lawsuit 6158 2